Skip to content
2000
Volume 20, Issue 14
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/13816128113199990472
2014-04-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/13816128113199990472
Loading

  • Article Type:
    Research Article
Keyword(s): (Pro)renin receptor; direct renin inhibitor; vascuolar H+-ATPase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test